Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.64SEK
−5.59 MSEK
24.16 MSEK
5.12 M
About ZENICOR MEDICAL SYSTEMS AB
Sector
Industry
CEO
Mats Håkan Palerius
Website
Headquarters
Stockholm
Employees (FY)
23
Founded
2003
ISIN
SE0006343984
FIGI
BBG0079S4JT6
Zenicor Medical Systems AB is a technology company, which engages in the development of arrhythmia investigations and stroke prevention. It focuses on cardiac arrhythmia diagnosis, atrial fibrillation, and professional healthcare through its One, Flex, View, and Direct solutions. The company was founded by Mats Håkan Palerius and Kjell Sonny Norström in 2003 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ZENI is 2.84 SEK — it has increased by 2.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange ZENICOR MEDICAL SYSTEMS AB stocks are traded under the ticker ZENI.
ZENICOR MEDICAL SYSTEMS AB is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
ZENI stock is 5.19% volatile and has beta coefficient of −0.70. Check out the list of the most volatile stocks — is ZENICOR MEDICAL SYSTEMS AB there?
ZENI earnings for the last quarter are 0.28 SEK per share, whereas the estimation was 0.36 SEK resulting in a −21.95% surprise. The estimated earnings for the next quarter are 0.04 SEK per share. See more details about ZENICOR MEDICAL SYSTEMS AB earnings.
ZENICOR MEDICAL SYSTEMS AB revenue for the last quarter amounts to 4.30 M SEK despite the estimated figure of 4.30 M SEK. In the next quarter revenue is expected to reach 3.70 M SEK.
Yes, you can track ZENICOR MEDICAL SYSTEMS AB financials in yearly and quarterly reports right on TradingView.
ZENI stock has risen by 1.43% compared to the previous week, the month change is a 5.33% fall, over the last year ZENICOR MEDICAL SYSTEMS AB has showed a 61.36% decrease.
ZENI net income for the last quarter is −1.18 M SEK, while the quarter before that showed −3.06 M SEK of net income which accounts for 61.36% change. Track more ZENICOR MEDICAL SYSTEMS AB financial stats to get the full picture.
Today ZENICOR MEDICAL SYSTEMS AB has the market capitalization of 25.62 M, it has decreased by 2.67% over the last week.
No, ZENI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ZENI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZENICOR MEDICAL SYSTEMS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 23.00 employees. See our rating of the largest employees — is ZENICOR MEDICAL SYSTEMS AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZENICOR MEDICAL SYSTEMS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZENICOR MEDICAL SYSTEMS AB stock shows the sell signal. See more of ZENICOR MEDICAL SYSTEMS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZENICOR MEDICAL SYSTEMS AB EBITDA is −1.07 M SEK, and current EBITDA margin is −10.73%. See more stats in ZENICOR MEDICAL SYSTEMS AB financial statements.